Catalent expanding Japanese manufacturing site to offer clinical services

Catalent's ($CTLT) site in Kakegawa, Japan, has been doing drug manufacturing and development for more than four decades, but never has produced clinical trial supplies. That is slated to change later this year. The Somerset, NJ-based company said it has already begun construction at the 200,000-square-foot facility that it expects to be complete in Q2. When open, it will allow Catalent to handle project management and clinical supply management, comparator sourcing, secondary packaging and labeling, clinical storage, distribution, and drug return and destruction. Release

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.